Securities code: 300639 stock abbreviation: Guangdong Hybribio Biotech Co.Ltd(300639) Announcement No.: 2022-007 Guangdong Hybribio Biotech Co.Ltd(300639)
Announcement on the completion of industrial and commercial establishment registration of holding subsidiaries
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Hybribio Biotech Co.Ltd(300639) (hereinafter referred to as “the company”) recently completed the industrial and commercial establishment registration of the holding subsidiary Guangzhou Kaipu Health Examination Center Co., Ltd. and obtained the business license issued by the market supervision and Administration Bureau of Huangpu District, Guangzhou. The relevant registration information is as follows:
1. Unified social credit Code: 91440101ma9yaa4cxd
2. Name: Guangzhou Kaipu Health Examination Center Co., Ltd
3. Type: limited liability company (sole proprietorship of legal person)
4. Address: 5 / F, production laboratory building, No. 71, Phoenix SANHENG Road, Huangpu District, Guangzhou (Zhongxin Guangzhou Knowledge City), legal representative: Guan Yuwei
6. Registered capital: RMB 20 million
7. Date of establishment: January 29, 2022
8. Long term business term: February 29, 20201
9. Business scope: general business items: information system integration services; Engaging in investment activities with its own funds; Medical equipment leasing; Health consulting services (excluding diagnosis and treatment services); Marketing planning; Sales of Arts and crafts and etiquette supplies (except ivory and its products); Wholesale of computer software, hardware and auxiliary equipment; Stationery wholesale; Information technology consulting services; Remote health management services; Big data services; business management; Data processing and storage support services; Biomass energy resource database information system platform; Non residential real estate leasing; Data processing services; Corporate image planning; estate management; Stationery retail; Technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion; Conference and exhibition services; Retail of computer software, hardware and auxiliary equipment; Advertising design and agency; Information consulting services (excluding licensed information consulting services); Consulting and planning services; Internet data services; Public AI data platform; Basic software development of artificial intelligence; Nursing institution services (excluding medical services); Clothing accessories sales; Clothing manufacturing; Software development; Enterprise management consulting; Health care services (non-medical);
Licensed business items: for clinic service business items, relevant licenses shall be obtained and approved by the license approval department and the health department; Internet hospital service business projects relying on physical hospitals need to obtain relevant licenses, which shall be approved by the industrial and information technology and health departments of the license approval department; Inspection and testing service business items need to obtain relevant licenses, which shall be approved by the license approval department and the market supervision department; Medical service business projects need to obtain relevant licenses, which shall be approved by the license approval department and the health department;
It is hereby announced.
Guangdong Hybribio Biotech Co.Ltd(300639) board of directors
February 8, 2002
